Colgate-Palmolive (NYSE:CL) Shares Purchased by Dai ichi Life Insurance Company Ltd

Dai ichi Life Insurance Company Ltd raised its stake in Colgate-Palmolive (NYSE:CLFree Report) by 120.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 230,954 shares of the company’s stock after acquiring an additional 126,133 shares during the quarter. Dai ichi Life Insurance Company Ltd’s holdings in Colgate-Palmolive were worth $18,409,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Morgan Stanley raised its holdings in shares of Colgate-Palmolive by 3.2% during the third quarter. Morgan Stanley now owns 16,815,987 shares of the company’s stock valued at $1,195,785,000 after acquiring an additional 514,559 shares during the last quarter. Northern Trust Corp lifted its holdings in Colgate-Palmolive by 3.3% in the 3rd quarter. Northern Trust Corp now owns 9,452,931 shares of the company’s stock valued at $672,198,000 after purchasing an additional 305,862 shares in the last quarter. Norges Bank acquired a new stake in Colgate-Palmolive during the 4th quarter worth $731,843,000. GUARDCAP ASSET MANAGEMENT Ltd grew its holdings in shares of Colgate-Palmolive by 1.3% during the fourth quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 6,709,304 shares of the company’s stock worth $534,799,000 after buying an additional 86,671 shares in the last quarter. Finally, American Century Companies Inc. lifted its stake in shares of Colgate-Palmolive by 2.0% in the third quarter. American Century Companies Inc. now owns 6,590,405 shares of the company’s stock worth $468,644,000 after buying an additional 127,805 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insider Buying and Selling at Colgate-Palmolive

In other news, insider Sally Massey sold 12,226 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the completion of the transaction, the insider now directly owns 13,924 shares in the company, valued at $1,309,691.44. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, insider Sally Massey sold 12,226 shares of the stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the completion of the sale, the insider now owns 13,924 shares in the company, valued at approximately $1,309,691.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider John W. Kooyman sold 3,497 shares of the stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total value of $326,864.59. Following the completion of the sale, the insider now directly owns 3,181 shares of the company’s stock, valued at $297,328.07. The disclosure for this sale can be found here. 0.37% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities analysts have weighed in on CL shares. Stifel Nicolaus boosted their target price on shares of Colgate-Palmolive from $94.00 to $95.00 and gave the company a “buy” rating in a report on Monday, April 29th. Argus increased their price objective on Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a research report on Wednesday, May 15th. Bank of America lifted their target price on Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a research report on Monday, April 29th. The Goldman Sachs Group began coverage on Colgate-Palmolive in a research report on Friday, March 1st. They set a “buy” rating and a $93.00 price objective for the company. Finally, Wells Fargo & Company upped their target price on shares of Colgate-Palmolive from $90.00 to $92.00 and gave the company an “equal weight” rating in a research report on Monday, April 29th. Three investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and a consensus target price of $92.35.

Check Out Our Latest Stock Report on CL

Colgate-Palmolive Trading Up 0.8 %

Shares of CL traded up $0.78 on Tuesday, hitting $95.17. 4,496,358 shares of the stock traded hands, compared to its average volume of 4,602,165. The firm has a market capitalization of $78.08 billion, a P/E ratio of 30.01, a P/E/G ratio of 3.47 and a beta of 0.40. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 13.21. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $95.59. The stock’s 50 day moving average is $89.93 and its two-hundred day moving average is $83.96.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, topping analysts’ consensus estimates of $0.82 by $0.04. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The company had revenue of $5.07 billion for the quarter, compared to the consensus estimate of $4.96 billion. During the same quarter last year, the firm posted $0.73 earnings per share. Colgate-Palmolive’s revenue was up 6.2% on a year-over-year basis. As a group, sell-side analysts predict that Colgate-Palmolive will post 3.53 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.10%. The ex-dividend date was Friday, April 19th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s payout ratio is currently 63.29%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.